[{"ap_syndicated":null,"collect_date":"2019-09-04 07:21:02.885866","feeds":null,"guid":"https://www.prnewswire.com:443/news-releases/monoclonal-antibody-therapeutics-to-drive-the-biotherapeutics-market-300911184.html","language":"en","media_id":19673,"media_name":null,"media_url":null,"processed_stories_id":null,"publish_date":"2019-09-04 07:12:00","stories_id":1382799594,"story_tags":[{"stories_id":1382799594,"tag":"geonames_3562981","tag_set":"mc-geocoder@media.mit.edu","tag_sets_id":1011,"tags_id":8878744},{"stories_id":1382799594,"tag":"geonames_3534168","tag_set":"mc-geocoder@media.mit.edu","tag_sets_id":1011,"tags_id":8880832},{"stories_id":1382799594,"tag":"geonames_3537906","tag_set":"mc-geocoder@media.mit.edu","tag_sets_id":1011,"tags_id":8880838},{"stories_id":1382799594,"tag":"nyt_labeller_v1.0.0","tag_set":"nyt_labels_version","tag_sets_id":1964,"tags_id":9360669},{"stories_id":1382799594,"tag":"medicine and health","tag_set":"nyt_labels","tag_sets_id":1963,"tags_id":9360852},{"stories_id":1382799594,"tag":"Sullivan","tag_set":"cliff_people","tag_sets_id":2389,"tags_id":9364857},{"stories_id":1382799594,"tag":"cliff_clavin_v2.4.1","tag_set":"geocoder_version","tag_sets_id":1937,"tags_id":9696677},{"stories_id":1382799594,"tag":"Frost & Sullivan","tag_set":"cliff_organizations","tag_sets_id":2388,"tags_id":9713191},{"stories_id":1382799594,"tag":"Mariana Fernandez","tag_set":"cliff_people","tag_sets_id":2389,"tags_id":29486117},{"stories_id":1382799594,"tag":"readability-lxml-0.7","tag_set":"extractor_version","tag_sets_id":1354,"tags_id":81092444},{"stories_id":1382799594,"tag":"Christi Bird","tag_set":"cliff_people","tag_sets_id":2389,"tags_id":92725875},{"stories_id":1382799594,"tag":"Alexei Voloshin","tag_set":"cliff_people","tag_sets_id":2389,"tags_id":183269649}],"title":"Monoclonal Antibody Therapeutics to Drive the Biotherapeutics Market","url":"https://www.prnewswire.com:443/news-releases/monoclonal-antibody-therapeutics-to-drive-the-biotherapeutics-market-300911184.html","word_count":null}]